Variant report
Variant | esv1002793 |
---|---|
Chromosome Location | chr5:45518325-45528668 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530794609 | chr5:45518325-45518326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577092201 | chr5:45518332-45518333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549384490 | chr5:45518345-45518346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545647475 | chr5:45518391-45518392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185154782 | chr5:45518417-45518418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576007499 | chr5:45518503-45518504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567857506 | chr5:45518504-45518505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140299914 | chr5:45518554-45518555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527276818 | chr5:45518580-45518581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540651937 | chr5:45518593-45518594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564410803 | chr5:45518627-45518628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533693054 | chr5:45518629-45518630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550063063 | chr5:45518681-45518682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528824177 | chr5:45518684-45518685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563906471 | chr5:45518704-45518705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545832611 | chr5:45518783-45518784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374757236 | chr5:45518850-45518851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62369088 | chr5:45518891-45518892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188874721 | chr5:45518898-45518899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34786654 | chr5:45518969-45518970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566207958 | chr5:45519001-45519002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192457904 | chr5:45519008-45519009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551816847 | chr5:45519038-45519039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570616875 | chr5:45519058-45519059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145203321 | chr5:45519075-45519076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556231612 | chr5:45519076-45519077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576177996 | chr5:45519145-45519146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs137887457 | chr5:45519148-45519149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373822461 | chr5:45519291-45519292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537041126 | chr5:45519335-45519336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555429051 | chr5:45519358-45519359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141063220 | chr5:45519431-45519432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571829201 | chr5:45519504-45519505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540589382 | chr5:45519505-45519506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571512064 | chr5:45519556-45519557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183926730 | chr5:45519576-45519577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369657023 | chr5:45519603-45519604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79092338 | chr5:45519628-45519629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544090414 | chr5:45519638-45519639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541629680 | chr5:45519799-45519800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529491346 | chr5:45519810-45519811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372401452 | chr5:45519815-45519816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549621552 | chr5:45519870-45519871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112113407 | chr5:45519901-45519902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533217954 | chr5:45519911-45519912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559854096 | chr5:45519919-45519920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114450263 | chr5:45519944-45519945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114992363 | chr5:45520081-45520082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150166879 | chr5:45520096-45520097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188266609 | chr5:45520133-45520134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:45518200-45518600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:45518600-45524000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:45520800-45521200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr5:45520800-45521200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr5:45521000-45521400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr5:45521400-45521800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
7 | chr5:45521400-45521800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
8 | chr5:45524000-45524200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr5:45524200-45526400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr5:45525800-45532800 | Weak transcription | Fetal Heart | heart |
11 | chr5:45526400-45526800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr5:45526400-45526800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |